Disclosure: This page contains affiliate links. We may earn a commission if you purchase through our links at no additional cost to you.
Red Light Therapy for Knee Pain (2026 Guide)
Red light therapy for knee pain: how photobiomodulation reduces osteoarthritis inflammation, accelerates tendon and cartilage repair, and supports recovery from knee injuries and surgery.
Knee pain limits almost everything you do. It is not just the pain itself. It is the stairs you avoid, the runs you cancel, the hours sitting at your desk where you cannot find a comfortable position. It colors everything. And because the knee is a weight-bearing joint that you cannot rest the way you rest a wrist or shoulder, it tends to drag on long past when you expect it to resolve.
The knee is a good place to look at what photobiomodulation does in a specific tissue, because the knee is a well-studied joint in the low-level laser therapy literature. Osteoarthritis research in particular is extensive, with multiple randomized controlled trials and meta-analyses. The mechanisms are well established. The protocols are more refined here than for many other applications. And the anatomy of the knee, a relatively accessible joint with its primary structures close to the skin surface, makes it well suited to photobiomodulation treatment.
This guide covers the conditions where photobiomodulation has the most evidence, the mechanisms driving those effects, how to structure a protocol for knee pain, and which devices make practical sense. It is a long guide because the knee is complex and the evidence base is substantial. But if you have chronic knee pain and are looking for something that does more than temporarily dull the signal, read through. The biology is worth understanding.
Why Knee Pain Is Different from Other Joint Pain
The knee is not a simple hinge. It is a modified hinge that also rotates slightly, has two separate joint compartments (medial and lateral), and relies almost entirely on soft tissue for stability because the bony architecture does not interlock the way the hip socket does. Four major ligaments, two menisci, multiple bursae, the patellofemoral joint, and the quadriceps-patellar tendon mechanism all contribute to normal knee function. When any component is irritated or damaged, the others compensate in ways that create secondary problems.
This interdependence means knee pain rarely has a single clean cause. Osteoarthritis in the medial compartment changes gait mechanics, which loads the IT band differently, which irritates the lateral knee, which alters quad activation patterns. A patellar tendinopathy changes how the quad fires during loading, which shifts load onto the joint surface. The knee is a system, and treating one component in isolation produces incomplete results. Photobiomodulation is useful here partly because it does not target one structure: it treats all the tissue in the irradiated zone simultaneously.
The other distinguishing feature of knee pain is load. You cannot meaningfully offload a knee the way you can a shoulder. Every step loads it. That sustained mechanical demand slows healing by repeatedly stressing tissue before it has had time to consolidate repair. Interventions that accelerate the cellular repair process without requiring full rest are valuable precisely because full rest is not a realistic option for most people.
How Red Light Therapy Works in Knee Tissue
Cartilage Metabolism and Protection
Articular cartilage is the main target in osteoarthritis, and it presents a biological challenge that makes it notoriously slow to heal: cartilage is avascular. No blood vessels run through it. Nutrients reach chondrocytes (the cells that maintain cartilage matrix) by diffusion from the synovial fluid and underlying subchondral bone. When cartilage is damaged or inflamed, this already slow nutrient delivery gets disrupted, and chondrocytes begin producing destructive enzymes (matrix metalloproteinases) that break down cartilage matrix faster than it can be replaced.
Photobiomodulation reaches chondrocytes through the tissue above them and appears to support chondrocyte metabolism directly. In vitro studies show photobiomodulation reduces MMP production in chondrocytes under inflammatory conditions and supports proteoglycan synthesis, one of the primary building blocks of cartilage matrix. In animal models of osteoarthritis, photobiomodulation treatment slows cartilage degradation compared to control. This is not cartilage regeneration in the full sense. Photobiomodulation does not rebuild cartilage that is already gone. What it does is support the chondrocytes that remain in maintaining what is there and slowing the progression of the breakdown.
Synovial Inflammation Reduction
The synovial membrane lining the knee joint becomes inflamed in osteoarthritis, rheumatoid arthritis, and after injury. Inflamed synovium produces pro-inflammatory cytokines that directly damage cartilage and sensitize the joint's nociceptors, producing pain that is out of proportion to the mechanical stimulus. This is why osteoarthritic knees often hurt more in cold or humid weather, or after periods of inactivity: the inflammatory mediators in the joint fluid sensitize the pain response even when you are not loading the joint.
Photobiomodulation reduces synovial inflammatory mediator production, including IL-1beta, IL-6, and TNF-alpha, through its effects on mitochondrial function and downstream signaling pathways. Reducing the synovial inflammatory burden directly reduces pain sensitization and the rate of cartilage damage, because many of the destructive enzymes are cytokine-driven. This is the mechanism most likely responsible for the consistent pain reduction seen in photobiomodulation trials for knee osteoarthritis.
Subchondral Bone and Bone Marrow Lesions
The subchondral bone beneath articular cartilage is increasingly recognized as a major pain source in knee osteoarthritis. Bone marrow lesions, areas of edema and altered bone metabolism visible on MRI, correlate strongly with pain intensity in knee OA. They result from abnormal loading patterns on compromised cartilage transferring forces directly into the bone, and from inflammatory mediators crossing the cartilage-bone interface.
Near-infrared light penetrates into the subchondral bone of the knee, which sits roughly 1 to 3cm below the skin surface depending on soft tissue thickness. The same mechanisms that support bone metabolism in the bone health literature apply here: photobiomodulation stimulates osteoblast activity, reduces osteoclast-mediated bone resorption, and improves local bone vascularity. For people with bone marrow lesions contributing to their knee pain, this adds a dimension to photobiomodulation's effects beyond what most people associate with joint treatment.
Tendon and Ligament Repair
The patellar tendon, quadriceps tendon, IT band, and the ligamentous structures of the knee respond well to photobiomodulation. Tendinopathy involves disorganized collagen repair, local hypoxia, neovascularization, and sensitized nociceptors within the tendon tissue. Photobiomodulation supports ordered collagen synthesis by tenocytes, improves local oxygenation, and reduces the neurogenic inflammatory component. For patellar tendinopathy specifically (common in athletes and active people with anterior knee pain), the evidence for photobiomodulation as part of a rehabilitation program is solid.
See NovaaLab Devices for Knee PainConditions with the Strongest Evidence
Knee Osteoarthritis
This is where the evidence is deepest. A 2022 systematic review and meta-analysis in Photobiomodulation, Photomedicine, and Laser Surgery reviewed 22 randomized controlled trials on photobiomodulation for knee osteoarthritis and found consistent, statistically significant reductions in pain (VAS scores) and improvements in physical function compared to sham. The effect sizes were clinically meaningful, not just statistically significant. The review noted that near-infrared wavelengths (808 to 830nm) produced larger effects than red alone, consistent with the deeper tissue targets in the knee.
An earlier Cochrane review found moderate-quality evidence that low-level laser therapy produced clinically meaningful pain reduction and functional improvement in knee OA, with effects maintained at up to 12 weeks of follow-up. The Cochrane methodology is conservative, so this finding carries weight. For a non-pharmacological intervention in osteoarthritis, producing effects that persist to 12 weeks without ongoing treatment is notable.
If you have knee osteoarthritis and have been told to manage it with NSAIDs, cortisone injections, and eventual joint replacement consideration, adding photobiomodulation is not a replacement for that care plan but a meaningful adjunct. The mechanisms are complementary: NSAIDs block the downstream inflammatory pathway. Photobiomodulation addresses the upstream cellular biology that drives the inflammation. They work differently and can work together.
Patellar Tendinopathy
Patellar tendinopathy (sometimes called jumper's knee, though it affects plenty of non-jumpers) is chronic degeneration of the patellar tendon where it attaches to the inferior pole of the patella. It is characterized by localized anterior knee pain on loading, stiffness after rest that improves with warm-up, and tenderness to direct palpation on the tendon. Conventional treatment involves load management, eccentric strengthening, and patience: tendons heal slowly.
Photobiomodulation as an adjunct to eccentric loading programs shows better outcomes than eccentric loading alone in several studies. The mechanism makes sense: you are providing optimal cellular conditions (improved collagen synthesis, reduced inflammatory mediators, better local oxygenation) at the same time you are applying the mechanical stimulus that drives tendon remodeling. Treating immediately before or after an eccentric loading session is a reasonable approach, so the tissue is in peak metabolic condition during or right after the rehab exercise stimulus.
Post-Surgical Knee Recovery
ACL reconstruction, meniscus repair, and total or partial knee replacement all benefit from photobiomodulation applied in the post-surgical period. The evidence for photobiomodulation in post-surgical soft tissue healing is consistent across sites: accelerated proliferative phase of healing, reduced scar formation, improved collagen organization in healing ligament and capsule tissue. For knee surgery specifically, where swelling, stiffness, and range-of-motion recovery are the main early challenges, photobiomodulation applied periarticularly (around the joint margins) in the first weeks post-surgery fits well alongside conventional physio.
One practical consideration for post-surgical use: clear it with your surgeon before starting. Most surgeons are supportive of or neutral toward photobiomodulation as an adjunct, but they need to know what interventions are being applied in the healing period. Early mobilization protocols in modern knee surgery already incorporate aggressive physio. Photobiomodulation complements that without conflicting with range-of-motion and strengthening work.
IT Band Syndrome
Iliotibial band syndrome is lateral knee pain from the IT band, a thick fibrous band running from the hip down the outside of the thigh, becoming irritated where it crosses the lateral femoral condyle. It is common in runners and cyclists, caused by repetitive friction of the band against the underlying tissue. Conventional treatment involves rest, foam rolling, and hip strengthening, with slow resolution in many cases because the underlying tissue irritation persists even when load is reduced.
Photobiomodulation applied to the lateral knee and lower IT band targets the inflamed bursa and periosteal tissue at the lateral condyle, reducing the inflammatory response that drives pain and local sensitization. For runners who cannot take extended breaks, integrating photobiomodulation as part of a load management and strengthening program gives the tissue support for active recovery rather than requiring full rest that most runners will not actually take.
Knee Bursitis
The knee has multiple bursae (prepatellar, infrapatellar, pes anserine) that can become inflamed from repetitive trauma, prolonged kneeling, or secondary to osteoarthritis. Bursitis produces localized swelling, warmth, and tenderness directly over the bursa. Photobiomodulation reduces bursal inflammation through the same cytokine-mediated mechanisms as synovial inflammation in the joint itself. Prepatellar bursitis (the classic "housemaid's knee") and pes anserine bursitis medially are the most common presentations and both sit superficially enough to be within effective treatment range even of shorter wavelengths.
See the Novaa Deep Healing Pad for Joint TreatmentAnatomy and Tissue Depth: What This Means for Treatment
The knee's therapeutic anatomy is favorable. The medial and lateral joint lines, the patellar tendon, the IT band insertion, and the prepatellar and infrapatellar spaces all sit within 1 to 3cm of the skin surface. Articular cartilage sits on the femoral condyles and tibial plateau beneath this, adding another 0.5 to 1cm depending on soft tissue. The synovial cavity itself is accessible from the medial, lateral, and suprapatellar approaches.
Near-infrared light at 850nm penetrates to 3 to 5cm in tissue, which puts virtually every relevant structure in the knee within effective treatment depth. This is one reason the knee OA research produces consistent results: the relevant tissue is actually within dosing range, unlike in deeper joints like the hip, where penetration to the articular surface is marginal even with high-irradiance devices.
The practical implication is that you need to cover multiple aspects of the knee to treat the whole joint. A single anterior placement covers the patellar tendon, infrapatellar fat pad, and the anterior femoral condyle surface well. Adding medial and lateral placements covers the joint compartments and collateral ligament structures. For a 15 to 20 minute session, anterior plus medial placement with the second half of the session is a reasonable routine for general knee OA treatment. For targeted conditions (patellar tendinopathy needs anterior, IT band needs lateral, Pes anserine bursitis needs medial), focus placement accordingly.
Protocol for Knee Pain
Wavelength Selection
For knee osteoarthritis and deep joint structures, near-infrared (850nm) is the priority wavelength. The depth penetration advantage over red (660nm) is significant when you are trying to reach cartilage, synovium, and subchondral bone rather than just the overlying soft tissue. For more superficial targets like patellar tendinopathy or bursitis, the combination of red plus near-infrared covers both surface and moderate depth. Most NovaaLab devices deliver both wavelengths simultaneously, which is the right choice for the knee's mixed depth targets.
Session Duration and Dosing
The photobiomodulation literature for knee OA uses protocols ranging from 60 to 120 seconds per point at probe-based devices, to 10 to 20 minutes with larger pad devices that cover the whole joint. For pad devices covering the anterior or medial knee, 12 to 15 minutes per placement is appropriate. If you are doing two placements per session (for example, anterior for 12 minutes then medial for 12 minutes), a 25-minute total session is reasonable and practical.
The biphasic dose-response relationship (more is not always better) is real with photobiomodulation, but it is more relevant at very high irradiances than at the therapeutic range typical devices operate in. At normal therapeutic irradiance, extending session time from 10 to 15 minutes increases dose without the risk of exceeding the optimal range for most people. Doubling session time does not double benefit, but it also does not cause harm.
Frequency
Daily sessions produce better outcomes than three times per week for chronic pain and osteoarthritis applications. The research protocols showing the best outcomes typically run sessions daily for the first 2 to 4 weeks, then drop to 5 sessions per week for maintenance. If daily sessions are not feasible, every other day maintains more therapeutic momentum than twice weekly. Front-loading frequency early in treatment matters. This is when the cumulative cellular effect builds fastest.
Timing and Adjuncts
For osteoarthritis, session timing relative to activity matters less than consistency. For tendinopathy rehabilitation, treating before eccentric loading exercise places the tendon in optimal metabolic condition during the mechanical stimulus. For post-activity soreness and swelling management, treating within an hour of exercise is preferable. Cold therapy (ice) and photobiomodulation are compatible and complementary: cold manages acute swelling and pain immediately post-activity. Photobiomodulation addresses the underlying tissue biology. Apply them sequentially rather than simultaneously, with photobiomodulation before ice if you do both.
See the Deep Healing Pad XL for Full Knee CoverageDevice Recommendations for Knee Pain
The knee's accessibility makes it forgiving with device selection: you are not trying to reach a deep joint with thick overlying muscle, so you do not need the highest-power device available. What matters more is coverage and ease of positioning. The knee is awkward to hold a device against for 15 minutes, so a flexible or hands-free setup is worth considering.
Best for Focused Knee Treatment: Novaa Deep Healing Pad
The Novaa Deep Healing Pad is the right starting point for most knee pain presentations. It is sized to cover the anterior knee joint in a single placement, flexible enough to wrap around the medial or lateral joint line, and delivers both red and near-infrared at therapeutic irradiance. Wrap it around the knee with a light elastic bandage to hold it in position and you have a hands-free setup that works while you sit. That practical advantage matters when you are committing to daily sessions: anything that requires active holding tends to get skipped.
Check Novaa Deep Healing Pad PriceBest for Bilateral Knee Treatment or Knee Plus Hip: Novaa Deep Healing Pad XL
If you have involvement in both knees (common with bilateral osteoarthritis), or if hip pain accompanies knee pain (also common, since the two are biomechanically linked), the Novaa Deep Healing Pad XL covers more surface area per session. For bilateral knees, you will still need two placements total, but the larger pad reduces the number of repositionings needed per knee. For the hip-plus-knee combination, the XL can cover the lateral hip in one session and the knee in a second, which is more efficient than trying to do four separate smaller sessions.
Check Deep Healing Pad XL PriceBest for Targeted Treatment: Novaa Light Pad
For localized conditions like patellar tendinopathy at a specific attachment point, prepatellar bursitis, or a specific joint line that is the primary pain source, the smaller Novaa Light Pad delivers precise coverage. When you know exactly where the problem is and want to concentrate treatment there rather than covering the whole joint, the smaller pad is more efficient. For acute localized pain (a direct contusion, a specific inflamed bursa), precision outweighs coverage.
Check Novaa Light Pad PriceWhat to Expect: Realistic Timeline
For acute knee pain from a strain or minor injury, meaningful improvement within 3 to 7 days of daily sessions is typical. The anti-inflammatory mechanisms work within 24 to 48 hours. Swelling reduction is usually visible in the first week. If you have an acute knee problem and start photobiomodulation early, you are working with the tissue's natural repair trajectory rather than trying to reverse months of chronic changes.
Knee osteoarthritis moves more slowly. This is not a limitation of photobiomodulation specifically. It reflects the nature of the tissue. Cartilage remodeling takes months, not weeks. What you can expect in the first 4 to 6 weeks is meaningful pain reduction and improved function, particularly morning stiffness, ease of stair climbing, and activity tolerance. The structural changes in the cartilage and synovium happen on a longer timeline. Research protocols showing the best outcomes run for 8 to 12 weeks, which is why effectiveness should not be judged after only 2 to 3 weeks in an osteoarthritis case.
Patellar tendinopathy sits between these two in terms of timeline. The pain often responds within 2 to 3 weeks of consistent treatment combined with load management. But tendons remodel slowly, and removing treatment prematurely because pain has improved is a common reason for relapse. Maintaining photobiomodulation for the full duration of the tendon rehab program, not just until symptoms reduce, gives better long-term outcomes.
Frequently Asked Questions
Can red light therapy replace cortisone injections for knee OA?
Not as an equivalent intervention in acute flares, but as an ongoing management tool it addresses mechanisms that cortisone does not. Cortisone reduces inflammation acutely and powerfully, but it does not change the biology of the joint long-term and repeated injections carry concerns about cartilage effects. Photobiomodulation works more slowly but supports cartilage metabolism, reduces synovial inflammation progressively, and can be used consistently without the risks associated with repeated injections. Many people use both: cortisone for acute severe flares, photobiomodulation for ongoing management. They are not mutually exclusive.
I have a knee replacement. Can I use red light therapy?
There are no established contraindications to photobiomodulation over a joint replacement. The metal implant reflects some of the light rather than absorbing it, so penetration to the implant surface itself is limited. What photobiomodulation reaches is the soft tissue surrounding the implant: the capsule, synovium, quadriceps tendon, and patellar tendon. For people with post-replacement stiffness, anterior knee pain, or soft tissue issues around the joint, those tissues benefit from photobiomodulation regardless of the implant. Clear it with your orthopedic surgeon as a courtesy, but expect no objection.
Does red light therapy help with meniscus tears?
The outer one-third of the meniscus (the red zone) has blood supply and can heal. Photobiomodulation supports the healing biology in that zone by accelerating the proliferative phase and improving collagen organization in the repair. The inner two-thirds (white zone) is avascular and cannot heal spontaneously. Photobiomodulation does not change that fundamental biology. For partial tears in the vascular zone, especially those managed conservatively, adding photobiomodulation to the rehab period is reasonable. For complex or bucket-handle tears requiring surgery, photobiomodulation is most useful post-operatively to support capsule and tissue healing around the surgical site.
How long should I treat each session for knee osteoarthritis?
12 to 15 minutes per placement, with 1 to 2 placements covering the affected compartment. For bilateral knee OA, 25 to 30 minutes total covers both knees. Daily sessions for the first 4 weeks, then 5 sessions per week is the protocol that most closely matches what the trials showing best outcomes used. If that frequency is not realistic, every other day maintains therapeutic momentum better than twice weekly.
My knee pain is worse after my first session. Should I stop?
A small proportion of people experience a transient increase in pain or stiffness after the first one or two sessions, similar to what can happen with manual therapy or dry needling. This is a known phenomenon with photobiomodulation and typically resolves within 24 to 48 hours. If it occurs, reduce session duration to 8 minutes for the next 3 to 4 sessions before building back to full length. This response does not predict poor outcomes. It just means the tissue is reacting more intensely to the initial stimulus and needs a graduated approach.
Can I use it while taking anti-inflammatory medications?
Yes. NSAIDs and photobiomodulation work through different pathways and are compatible. NSAIDs inhibit COX enzymes in the inflammatory cascade. Photobiomodulation works upstream through mitochondrial and cytokine mechanisms. They address different aspects of the same problem. Many rheumatologists and physiotherapists who use photobiomodulation clinically use it alongside standard pharmacological management without modification to either.
Final Thoughts
Knee osteoarthritis is one of the two or three strongest evidence categories in the entire photobiomodulation literature. Multiple systematic reviews, a Cochrane review, and dozens of individual trials with sham controls consistently show meaningful pain reduction and functional improvement. That is not common in musculoskeletal medicine, where effect sizes are often small and study quality is variable. The knee OA evidence is among the best in the field.
What makes photobiomodulation particularly suited to the knee is the combination of accessible anatomy and multi-target mechanisms. The joint's structures sit within effective penetration depth. The intervention hits cartilage metabolism, synovial inflammation, subchondral bone, tendon repair, and neural sensitization simultaneously. No single pharmacological or physical therapy intervention touches that many components at once without significant trade-offs.
The device investment is not trivial. But compared to years of NSAID use with gastrointestinal and cardiovascular trade-offs, repeated cortisone injections, or the cost and recovery of surgical intervention, a quality photobiomodulation device that you own and use daily for an indefinite period is reasonable on both economic and biological grounds. NovaaLab's 60-day trial removes the commitment risk: run a genuine 8-week protocol at daily frequency and evaluate real outcomes before deciding whether to keep it.
Try NovaaLab Risk-Free for 60 Days